Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), responded to the White House’s recent announcement on autism with a statement emphasizing the role of life sciences companies in health care.
“From rigorous R&D and clinical trials to comprehensive approval and regulatory processes, life sciences companies have long partnered with safety and efficacy agencies in the U.S. and globally to ensure that patient safety remains the cornerstone of advancing human health. They remain committed to upholding the highest standards of scientific integrity and medical safety as they pursue their mission: to improve and save lives worldwide,” Buteas stated.
The White House announcement referenced by HINJ addressed new initiatives related to autism, though further details were not included in Buteas’ statement.
